Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues.

World journal of gastroenterology - 28 Dec 2012

Song Zhuo-Lun, Cui Yu-Jun, Zheng Wei-Ping, Teng Da-Hong, Zheng Hong

Abstract excerpt

Nucleos(t)ide analogues (NA) are a breakthrough in the treatment and management of chronic hepatitis B. NA could suppress the replication of hepatitis B virus (HBV) and control the progression of the disease. However, drug resistance caused by their long-term use becomes a practical problem, whic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Multiple
Share to Guanine
Share to Hepatitis B e Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lamivudine

Share to Liver Transplantation

Share to Nucleosides

Share to Organophosphonates

Share to Tenofovir

Source

Open in PubMed Open full text

Identifiers

PMID: 23326119
DOI: 10.3748/wjg.v18.i48.7149
PMCID: PMC3544016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23326119-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues.PMID 23326119Read ↗

Evolution of drug-resistant mutations in HBV genomes in patients with treatment failure during the past seven years (2010-2016).Semantic proximity Read ↗

Hepatitis B virus drug resistance to current nucleos(t)ide analogs: Mechanisms and mutation sitesSemantic proximity Read ↗

Trends in hepatitis B virus resistance to nucleoside/nucleotide analogues in North China from 2009-2016: A retrospective study.Semantic proximity Read ↗

Comparison of Detection Rate and Mutational Pattern of Drug-Resistant Mutations Between a Large Cohort of Genotype B and Genotype C Hepatitis B Virus-Infected Patients in North China.Semantic proximity Read ↗

Prevalence and types of drug-resistant variants in Chinese patients with acute hepatitis B.Semantic proximity Read ↗

Discrepancy of potential antiviral resistance mutation profiles within the HBV reverse transcriptase between nucleos(t)ide analogue-untreated and -treated patients with chronic hepatitis B in a hospital in China.Semantic proximity Read ↗

Monitoring of genotypic resistance profile in chronic hepatitis B patients receiving nucleos(t)ide analogues in Huzhou, China.Semantic proximity Read ↗

Hepatitis B: treatment choice and monitoring for response and resistance.Semantic proximity Read ↗

Management of antiviral drug resistance in chronic hepatitis B.Semantic proximity Read ↗

Current developments in nucleoside/nucleotide analogues for hepatitis B.Semantic proximity Read ↗

Evaluation of Hepatitis B Virus Nucleos(t)ide Analogues Resistance mutations in Treatment-Naïve Patients: A Systematic Review and Meta-AnalysisSemantic proximity Read ↗

Chronic hepatitis B therapy: available drugs and treatment guidelines.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.